Polymorphisms of TNF-alpha and LT-alpha genes in multiple myeloma.
暂无分享,去创建一个
R. Ádány | A. Tordai | B. Melegh | Á. Szilágyi | M. Kovács | Z. Pocsai | G. Mikala | I. Karádi | G. Füst | J. Várkonyi | K. Kádár | K. Kadar | M. Kovács
[1] R. Ádány,et al. The 8.1 ancestral MHC haplotype is strongly associated with colorectal cancer risk , 2007, International journal of cancer.
[2] L. Staudt,et al. Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. , 2007, Cancer cell.
[3] L. Bruhn,et al. Promiscuous mutations activate the noncanonical NF-kappaB pathway in multiple myeloma. , 2007, Cancer cell.
[4] N. Rothman,et al. Common variants in genes that mediate immunity and risk of multiple myeloma , 2007, International journal of cancer.
[5] C. Caruso,et al. Genetic Control of Immune Response in Carriers of Ancestral Haplotype 8.1 , 2006, Annals of the New York Academy of Sciences.
[6] M. Rewers,et al. Extreme genetic risk for type 1A diabetes , 2006, Proceedings of the National Academy of Sciences.
[7] B. Melegh,et al. Decreased frequency of the TNF2 allele of TNF-alpha -308 promoter polymorphism is associated with lacunar infarction. , 2006, Cytokine.
[8] K. Welsh,et al. MHC class II, tumour necrosis factor α, and lymphotoxin α gene haplotype associations with serological subsets of systemic lupus erythematosus , 2005, Annals of the rheumatic diseases.
[9] B. Burkhardt,et al. Tumor necrosis factor and lymphotoxin alfa genetic polymorphisms and outcome in pediatric patients with non-Hodgkin's lymphoma: results from Berlin-Frankfurt-Münster Trial NHL-BFM 95. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] E. Thorsby,et al. Systemic lupus erythematosus and the extended major histocompatibility complex--evidence for several predisposing loci. , 2005, Rheumatology.
[11] S. Rollinson,et al. Haplotypes in the tumour necrosis factor region and myeloma , 2005, British journal of haematology.
[12] R. Ádány,et al. A preliminary evaluation of a health monitoring programme in Hungary. , 2005, European journal of public health.
[13] K. Calame,et al. Plasma cell differentiation and multiple myeloma. , 2004, Current opinion in immunology.
[14] E. Khusnutdinova,et al. Molecular Genetic Analysis of the Interleukin 6 and Tumor Necrosis Factor α Gene Polymorphisms in Multiple Myeloma , 2003, Molecular Biology.
[15] M. Cuccia,et al. Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: a genetically determined defect of C4 influences immunological parameters of healthy carriers of the haplotype. , 2003, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[16] H. Goldschmidt,et al. Polymorphisms of the tumor necrosis factor-alpha gene promoter predict for outcome after thalidomide therapy in relapsed and refractory multiple myeloma. , 2002, Blood.
[17] C. Caruso,et al. Pathogenesis of autoimmune diseases associated with 8.1 ancestral haplotype: effect of multiple gene interactions. , 2002, Autoimmunity reviews.
[18] Ruben Gamboa,et al. Heat shock protein 70 gene polymorphisms in Mexican patients with spondyloarthropathies , 2002, Annals of the rheumatic diseases.
[19] M. Čolović,et al. Correlation of sera TNF-alpha with percentage of bone marrow plasma cells, LDH, beta2-microglobulin, and clinical stage in multiple myeloma. , 2002, Medical Oncology.
[20] P. Grant,et al. Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy. , 2001, Diabetes.
[21] R. Locksley,et al. The TNF and TNF Receptor Superfamilies Integrating Mammalian Biology , 2001, Cell.
[22] E Roman,et al. High-producer haplotypes of tumor necrosis factor alpha and lymphotoxin alpha are associated with an increased risk of myeloma and have an improved progression-free survival after treatment. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] M. Björkholm,et al. Interleukin 6, tumour necrosis factor α, interleukin 1β and interleukin 1 receptor antagonist promoter or coding gene polymorphisms in multiple myeloma , 2000 .
[24] M. Björkholm,et al. Interleukin 6, tumour necrosis factor alpha, interleukin 1beta and interleukin 1 receptor antagonist promoter or coding gene polymorphisms in multiple myeloma. , 2000, British journal of haematology.
[25] K. Tarte,et al. Tumor necrosis factor is a survival and proliferation factor for human myeloma cells. , 1999, European cytokine network.
[26] M. Walker,et al. Tumour necrosis factor-alpha gene promoter polymorphism and decreased insulin resistance , 1998, Diabetologia.
[27] H. Mcdevitt,et al. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[28] T. Espevik,et al. THE ROLE OF THE TWO TNF RECEPTORS IN PROLIFERATION, NF-κB ACTIVATION AND DISCRIMINATION BETWEEN TNF AND LTαSIGNALLING IN THE HUMAN MYELOMA CELL LINE OH-2 , 1996 .
[29] T. Espevik,et al. The role of the two TNF receptors in proliferation, NF-kappa B activation and discrimination between TNF and LT alpha signalling in the human myeloma cell line OH-2. , 1996, Cytokine.
[30] A. Waage,et al. TNF and IL‐6 are potent growth factors for OH‐2, a novel human myeloma cell line , 1994, European journal of haematology.
[31] I. Udalova,et al. DNA sequence polymorphism at the human tumor necrosis factor (TNF) locus. Numerous TNF/lymphotoxin alleles tagged by two closely linked microsatellites in the upstream region of the lymphotoxin (TNF-beta) gene. , 1991, Journal of immunology.
[32] U. Spengler,et al. Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF- beta production , 1991, The Journal of experimental medicine.
[33] Shirley A. Miller,et al. A simple salting out procedure for extracting DNA from human nucleated cells. , 1988, Nucleic acids research.
[34] D. Goeddel,et al. Human lymphotoxin and tumor necrosis factor genes: structure, homology and chromosomal localization. , 1985, Nucleic acids research.
[35] J. McCluskey,et al. Disease Associations with Complotypes, Supratypes and Haplotypes , 1983, Immunological reviews.
[36] S. Salmon,et al. A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival , 1975, Cancer.